Bio-TechneTECHEarnings & Financial Report
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
TECH Q2 2026 Key Financial Metrics
营收
$295.9M
毛利润
$191.3M
营业利润
$54.5M
净利润
$38.0M
毛利率
64.6%
营业利润率
18.4%
净利率
12.8%
同比增长
-6.4%
EPS
$0.24
资金流向
Bio-Techne Q2 2026 Financial Summary
Bio-Techne reported revenue of $295.9M for Q2 2026, with a net profit of $38.0M (12.8% margin). Cost of goods sold was $104.6M, operating expenses totaled $136.8M.
Key Financial Metrics
| Total Revenue | $295.9M |
|---|---|
| Net Profit | $38.0M |
| Gross Margin | 64.6% |
| Operating Margin | 18.4% |
| Report Period | Q2 2026 |
Bio-Techne Annual Revenue by Year
Bio-Techne annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.2B |
| 2024 | $1.2B |
| 2023 | $1.1B |
| 2022 | $1.1B |
利润表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $303.4M | $289.5M | $297.0M | $316.2M | $316.2M | $286.6M | $295.9M | $295.9M |
| 同比增长 | 3.2% | 4.5% | 9.0% | 4.2% | 4.2% | -1.0% | -0.4% | -6.4% |
资产负债表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $2.70B | $2.74B | $2.67B | $2.64B | $2.56B | $2.53B | $2.52B | $2.52B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $2.07B | $2.14B | $2.08B | $2.02B | $1.92B | $1.97B | $2.01B | $2.01B |
现金流量表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 经营性现金流 | $75.5M | $63.9M | $84.3M | $41.1M | $98.2M | $27.6M | $82.4M |
Other Health Care Companies
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
CRL
Charles River Laboratories
营收
$994.2M
净利润
$-276.6M
DHR
Danaher Corporation
营收
$6.1B
净利润
$908.0M
IQV
IQVIA
营收
$4.4B
净利润
$514.0M
MTD
Mettler Toledo
营收
$1.1B
净利润
$285.8M
TMO
Thermo Fisher Scientific
营收
$11.1B
净利润
$1.6B
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B